Snowden Capital Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Snowden Capital Advisors LLC

$3.12 Billion
Q4 2024

A detailed history of Snowden Capital Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 1,617 shares of REGN stock, worth $1.11 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,617

Previous 1,509 7.16%

Holding current value

$1.11 Million

Previous $1.59 Million 27.43%

% of portfolio

0.04%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $75,799 - $113,066	108 Added 7.16%	1,617 $1.15 Million
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $183,312 - $215,115	-179 Reduced 10.6%	1,509 $1.59 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $135,129 - $163,892	-153 Reduced 8.31%	1,688 $1.77 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $612,926 - $674,484	679 Added 58.43%	1,841 $1.77 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $27,906 - $31,741	36 Added 3.2%	1,162 $1.02 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $50,548 - $61,639	-73 Reduced 6.09%	1,126 $926,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $51,102 - $60,615	73 Added 6.48%	1,199 $861,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $161,956 - $196,818	-238 Reduced 17.45%	1,126 $925,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $66,353 - $72,040	-94 Reduced 6.45%	1,364 $984,000
Q3 2022 Nov 09, 2022	SELL	$573.97 - $724.32 $95,852 - $120,961	-167 Reduced 10.28%	1,458 $1 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $169,440 - $228,301	-309 Reduced 15.98%	1,625 $960,000
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $699,266 - $820,655	1,175 Added 154.81%	1,934 $1.35 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $412,501 - $509,266	759 New	759 $479,000
Q3 2021 Feb 05, 2024	BUY	$574.03 - $680.96 $392,636 - $465,776	684 Added 60.75%	1,810 $1.1 Billion
Q2 2021 Jan 08, 2024	BUY	$472.8 - $558.54 $148,459 - $175,381	314 Added 21.14%	1,799 $1 Billion
Q1 2021 Jan 08, 2024	BUY	$446.73 - $548.2 $335,047 - $411,150	750 Added 102.04%	1,485 $703 Million
Q4 2020 Jan 08, 2024	BUY	$478.3 - $607.98 $106,182 - $134,971	222 Added 43.27%	735 $355 Million
Q3 2020 Jan 08, 2024	BUY	$544.75 - $658.21 $4,902 - $5,923	9 Added 1.79%	513 $287 Million
Q2 2020 Jan 08, 2024	SELL	$493.32 - $643.92 $10,853 - $14,166	-22 Reduced 4.18%	504 $314 Million
Q1 2020 Jan 08, 2024	BUY	$336.18 - $494.43 $176,830 - $260,070	526 New	526 $257 Million
Q4 2019 Jan 08, 2024	SELL	$274.13 - $376.51 $14 Million - $19.2 Million	-50,900 Closed	0 $0
Q3 2019 Jan 08, 2024	SELL	$273.46 - $318.39 $20.3 Million - $23.6 Million	-74,100 Reduced 59.28%	50,900 $141 Million
Q2 2019 Jan 08, 2024	BUY	$299.6 - $414.82 $37.3 Million - $51.6 Million	124,489 Added 24361.84%	125,000 $155 Million
Q1 2019 Jan 08, 2024	SELL	$372.08 - $439.57 $228,829 - $270,335	-615 Reduced 54.62%	511 $210 Million

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.43M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History